Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 10-2021 | 12-2017 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 137 | N/A |
| Marketable Securities | 205 | N/A |
| Receivables | 104 | N/A |
| Other current assets | 15 | 0 |
| TOTAL | $461 | $N/A |
| Non-Current Assets | ||
| PPE Net | 14 | N/A |
| TOTAL | $14 | $N/A |
| Total Assets | $876 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| TOTAL | $2,049 | $N/A |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $2,049 | $N/A |
| Shareholders' Equity | ||
| Shares Outstanding, K | 82 | N/A |
| Retained earnings | -10,759 | N/A |
| Other shareholders' equity | 9,586 | 0 |
| TOTAL | $-1,173 | $N/A |
| Total Liabilities And Equity | $876 | $0 |